MICHELLE A FANALE to Patient Reported Outcome Measures
This is a "connection" page, showing publications MICHELLE A FANALE has written about Patient Reported Outcome Measures.
Connection Strength
0.107
-
Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Leuk Lymphoma. 2019 11; 60(11):2705-2711.
Score: 0.107
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.